Cargando…
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis
BACKGROUND: Multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS), can be suppressed in its early stages but eventually becomes clinically progressive and unresponsive to therapy. Here, we investigate whether the therapeutic resistance of progressive MS can be attributed...
Autores principales: | Kaufmann, Max, Evans, Hayley, Schaupp, Anna-Lena, Engler, Jan Broder, Kaur, Gurman, Willing, Anne, Kursawe, Nina, Schubert, Charlotte, Attfield, Kathrine E., Fugger, Lars, Friese, Manuel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966680/ https://www.ncbi.nlm.nih.gov/pubmed/33748804 http://dx.doi.org/10.1016/j.medj.2021.01.006 |
Ejemplares similares
-
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
por: Wurm, Hannah, et al.
Publicado: (2020) -
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
por: Gregory, Adam P., et al.
Publicado: (2012) -
A novel neurodegenerative spectrum disorder in patients with MLKL deficiency
por: Faergeman, Soren L., et al.
Publicado: (2020) -
Structural and regulatory diversity shape HLA-C protein expression levels
por: Kaur, Gurman, et al.
Publicado: (2017) -
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor
por: Rühl, Geraldine, et al.
Publicado: (2016)